CHRISTIE MASE: Open Payments
NPI 1336923432 · MAYNARDVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 27 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $473 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $90 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| ABBVIE INC. | 3 | $56 |
| Lundbeck LLC | 2 | $38 |
| Novo Nordisk Inc | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Lilly USA, LLC | 2 | $29 |
| Exact Sciences Corporation | 1 | $20 |
Products named: TRELEGY ELLIPTA, REXULTI, Wegovy, Auvelity, VRAYLAR, HETLIOZ, CAPLYTA, JARDIANCE.
Industry payments across TN — which companies pay providers there.
